Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Cose

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
Frontiers in Neurology|January 2, 2025
Changes in serum concentration of perioperative inflammatory cytokines following the timing of surgery among mild-moderate traumatic brain injury patients and factors associatedHervé Monka Lekuya, Stephen Cose, Marjorie Nakibuule, et al.
Plos One|July 24, 2024
Metagenomic sequencing of the skin microbiota of the scalp predicting the risk of surgical site infections following surgery of traumatic brain injury in sub-Saharan AfricaHervé Monka Lekuya, David Patrick Kateete, Geofrey Olweny, et al.
Plos Neglected Tropical Diseases|May 5, 2017
The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trialAnne Wajja, Dennison Kizito, Beatrice Nassanga, et al.
Open Forum Infectious Diseases|June 11, 2021
Latent Tuberculosis Infection Status of Pregnant Women in Uganda Determined Using QuantiFERON TB Gold-PlusFelix Bongomin, Phillip Ssekamatte, Gloria Nattabi, et al.
Viruses|May 18, 2016
Correspondence of Neutralizing Humoral Immunity and CD4 T Cell Responses in Long Recovered Sudan Virus SurvivorsAriel Sobarzo, Spencer W Stonier, Andrew S Herbert, et al.
Wellcome Open Research|January 29, 2019
Lessons from the first clinical trial of a non-licensed vaccine among Ugandan adolescents: a phase II field trial of the tuberculosis candidate vaccine, MVA85AAnne Wajja, Milly Namutebi, Barbara Apule, et al.
Parasite Immunology|September 22, 2018
Antibody responses to Schistosoma mansoni schistosomula antigensMoses Egesa, Lawrence Lubyayi, Frances M Jones, et al.
Plos One|May 20, 2026
Practical guidelines for producing non-replicating canine adenovirus vectorsDenis Omara, Christian Ndekezi, Susan Mugaba, et al.
Frontiers in Immunology|June 2, 2020
Maternal Latent <i>Mycobacterium tuberculosis</i> Does Not Affect the Infant Immune Response Following BCG at Birth: An Observational Longitudinal Study in UgandaLawrence Lubyayi, Patrice A Mawa, Grace Nabakooza, et al.
Frontiers in Immunology|December 22, 2023
Feasibility and acceptability of undertaking postmortem studies for tuberculosis medical research in a low income countryGift Ahimbisibwe, Marjorie Nakibuule, Marvin Martin Ssejoba, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
Frontiers in Neurology|January 2, 2025
Changes in serum concentration of perioperative inflammatory cytokines following the timing of surgery among mild-moderate traumatic brain injury patients and factors associatedHervé Monka Lekuya, Stephen Cose, Marjorie Nakibuule, et al.
Plos One|July 24, 2024
Metagenomic sequencing of the skin microbiota of the scalp predicting the risk of surgical site infections following surgery of traumatic brain injury in sub-Saharan AfricaHervé Monka Lekuya, David Patrick Kateete, Geofrey Olweny, et al.
Plos Neglected Tropical Diseases|May 5, 2017
The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trialAnne Wajja, Dennison Kizito, Beatrice Nassanga, et al.
Open Forum Infectious Diseases|June 11, 2021
Latent Tuberculosis Infection Status of Pregnant Women in Uganda Determined Using QuantiFERON TB Gold-PlusFelix Bongomin, Phillip Ssekamatte, Gloria Nattabi, et al.
Viruses|May 18, 2016
Correspondence of Neutralizing Humoral Immunity and CD4 T Cell Responses in Long Recovered Sudan Virus SurvivorsAriel Sobarzo, Spencer W Stonier, Andrew S Herbert, et al.
Wellcome Open Research|January 29, 2019
Lessons from the first clinical trial of a non-licensed vaccine among Ugandan adolescents: a phase II field trial of the tuberculosis candidate vaccine, MVA85AAnne Wajja, Milly Namutebi, Barbara Apule, et al.
Parasite Immunology|September 22, 2018
Antibody responses to Schistosoma mansoni schistosomula antigensMoses Egesa, Lawrence Lubyayi, Frances M Jones, et al.
Plos One|May 20, 2026
Practical guidelines for producing non-replicating canine adenovirus vectorsDenis Omara, Christian Ndekezi, Susan Mugaba, et al.
Frontiers in Immunology|June 2, 2020
Maternal Latent <i>Mycobacterium tuberculosis</i> Does Not Affect the Infant Immune Response Following BCG at Birth: An Observational Longitudinal Study in UgandaLawrence Lubyayi, Patrice A Mawa, Grace Nabakooza, et al.
Frontiers in Immunology|December 22, 2023
Feasibility and acceptability of undertaking postmortem studies for tuberculosis medical research in a low income countryGift Ahimbisibwe, Marjorie Nakibuule, Marvin Martin Ssejoba, et al.
Pageof 10